Shanu Modi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shanu modi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shanu Modi Today - Breaking & Trending Today

A New Type of Cancer Drug Shrinks Hard-to-Treat Tumors

New drugs called antibody-drug conjugates help patients with cancers that used to be beyond treatment ....

United States , Dana Farber Cancer Institute , New York , Matthew Vander Heiden , Daiichi Sankyo , Joshuaz Drago , Davidj Benjamin , Greg Thurber , Saram Tolaney , Sloan Kettering , University Of Michigan , Hoag Family Cancer Institute , Massachusetts Institute Of Techonology , Cancer Center , Drug Administration , Koch Institute , Shanu Modi , Memorial Sloan Kettering , New York City , Massachusetts Institute ,

Dr Modi on Updated OS Data From the DESTINY-Breast04 Trial of T-DXd in HER2-Low Breast Cancer

Shanu Modi, MD, discusses updated survival data from the phase 3 DESTINY-Breast04 trial evaluating fam-trastuzumab deruxtecan-nxki in patients with HER2-low metastatic breast cancer.
....

Memorial Sloan Kettering Cancer Center , Shanu Modi , Trastuzumab Deruxtecan In Patients With Her2 Low Breast Cancer , Patients With Unresectable Or Metastatic Her2 Low Breast Cancer , Destiny Breast04 Trial , Patients With Hormone Receptor Positive , Her2 Low Metastatic Breast Cancer ,

T-DXd Benefits Persist for HER2-Low Breast Cancer

Trastuzumab deruxtecan (T-DXd) provided sustained clinically meaningful improvement versus physician’s choice of treatment (TPC) for patients with advanced breast cancer and low HER2 expression. ....

New York , United States , Memorial Sloan Kettering Cancer Center , Giampaolo Bianchini , European Society Of Medical Oncology , Shanu Modi , European Society , Medical Oncology , San Raffaele , Breast Cancer , Alignant Breast Neoplasm , Metastatic Breast Carcinoma , Biologic Therapy , Alignant Neoplasia , Antineoplastic Drug , Nti Cancer Agents , Antibody Drug Conjugates Adcs , Oncological Medicine ,

Trastuzumab Deruxtecan Sustains Survival Benefits in HER2-Low Metastatic Breast Cancer

Treatment with fam-trastuzumab deruxtecan-nxki led to sustained improvements in overall survival and progression-free survival vs physician’s choice of treatment in patients with previously treated HER2-low metastatic breast cancer, irrespective of hormone receptor status. ....

Memorial Sloan Kettering Cancer Center , Shanu Modi ,

Living With Metastatic Breast Cancer: A Mother's Story of Hope | Memorial Sloan Kettering Cancer Center

Learn how MSK's expertise in metastatic breast cancer helped a mother celebrate a long-awaited milestone with her family. ....

New York , United States , Memorial Sloan Kettering Cancer Center , Jasmeet Singh , Melissa Zinovoy , Emma Mon , Metastatic Breast Cancer Alliance , Purdue University , Utah Zion National Park , New York City , Memorial Sloan Kettering Cancer , New Era , Treating Metastatic Breast , Zion National , Shanu Modi ,